| Mass Balance Clinical Trial With TEV-56286 (NCT06627231) | Teva Branded Pharmaceutical Products R&D, Inc. | 2024-10-08 |
| Pharmacokinetic Profile and Safety of Fluticasone Propionate and Albuterol Sulfate in Combination When Compared to Fluticasone Propionate Multidose Dry Powder Inhaler (Fp MDPI) in Children Aged 4 to 11 Years Old (NCT06290102) | Teva Branded Pharmaceutical Products R&D, Inc. | 2024-05-16 |
| A Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label Period on Efficacy and Safety of Fremanezumab in Chinese Adults With Migraine (NCT05458011) | Teva Branded Pharmaceutical Products R&D, Inc. | 2022-09-30 |
| A Study to Test the Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease (NCT05499130) | Teva Branded Pharmaceutical Products R&D, Inc. | 2022-09-30 |
| A Study to Test if TEV-53275 is Effective in Relieving Asthma (NCT04847674) | Teva Branded Pharmaceutical Products R&D, Inc. | 2021-05-04 |
| A 24-Week Treatment Study to Compare Standard of Care Versus the eMDPI DS in Participants 13 Years or Older With Asthma (NCT04677959) | Teva Branded Pharmaceutical Products R&D, Inc. | 2021-02-16 |
| A 12-Week Treatment Study to Evaluate the Effectiveness of Albuterol Multidose Dry Powder Inhaler With Integrated Electronic Module Digital System (eMDPI DS) in Participants13 Years or Older With Asthma (NCT03890666) | Teva Branded Pharmaceutical Products R&D, Inc. | 2020-10-26 |
| A Study to Test if TEV-48574 is Effective in Relieving Asthma (NCT04545385) | Teva Branded Pharmaceutical Products R&D, Inc. | 2020-10-07 |
| A Study to Test if Fremanezumab is Effective in Preventing Chronic Migraine in Participants 6 to 17 Years of Age (NCT04464707) | Teva Branded Pharmaceutical Products R&D, Inc. | 2020-09-24 |
| A Study to Test if Fremanezumab is Effective in Preventing Episodic Migraine in Patients 6 to 17 Years of Age (NCT04458857) | Teva Branded Pharmaceutical Products R&D, Inc. | 2020-07-15 |
| A Study to Test if TEV-50717 is Safe and Effective in Relieving Abnormal Involuntary Movements in Cerebral Palsy (NCT04200352) | Teva Branded Pharmaceutical Products R&D, Inc. | 2020-02-04 |
| A Study to Evaluate the Efficacy and Safety of Fremanezumab for Preventive Treatment of Migraine in Patients With Major Depressive Disorder (NCT04041284) | Teva Branded Pharmaceutical Products R&D, Inc. | 2019-09-13 |
| A Study of TEV-50717 (Deutetrabenazine) for the Treatment of Dyskinesia in Cerebral Palsy in Children and Adolescents (NCT03813238) | Teva Branded Pharmaceutical Products R&D, Inc. | 2019-08-06 |
| A Study to Test the Effectiveness and Safety of Fremanezumab on Participants With Fibromyalgia (NCT03965091) | Teva Branded Pharmaceutical Products R&D, Inc. | 2019-07-31 |
| A Study to Test if TV-46000 is Safe for Maintenance Treatment of Schizophrenia (NCT03893825) | Teva Branded Pharmaceutical Products R&D, Inc. | 2019-04-17 |
| A Study to Evaluate Injection Pain and Local Tolerability Following Subcutaneous (SC) Administration of TV-46046 (NCT03700658) | Teva Branded Pharmaceutical Products R&D, Inc. | 2019-01-15 |
| A Study to Test if TEV-50717 is Effective in Relieving Tics Associated With Tourette Syndrome (TS) (NCT03571256) | Teva Branded Pharmaceutical Products R&D, Inc. | 2018-05-31 |
| Evaluation of Safety and Tolerability of Long-term TEV-50717 (Deutetrabenazine) for Treatment of Tourette Syndrome in Children and Adolescents (NCT03567291) | Teva Branded Pharmaceutical Products R&D, Inc. | 2018-05-25 |
| Study to Evaluate TV-46000 as Maintenance Treatment in Adult and Adolescent Participants With Schizophrenia (NCT03503318) | Teva Branded Pharmaceutical Products R&D, Inc. | 2018-04-27 |
| Alternatives for Reducing Tics in Tourette Syndrome (TS): A Study of TEV-50717 (Deutetrabenazine) for the Treatment of Tourette Syndrome in Children and Adolescents (NCT03452943) | Teva Branded Pharmaceutical Products R&D, Inc. | 2018-02-05 |
| A Study to Test if Fremanezumab Reduces Headache in Participants With Posttraumatic Headache (PTH) (NCT03347188) | Teva Branded Pharmaceutical Products R&D, Inc. | 2017-12-18 |
| An Efficacy and Safety Study of Fremanezumab in Adults With Migraine (NCT03308968) | Teva Branded Pharmaceutical Products R&D, Inc. | 2017-10-13 |
| Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Chronic Obstructive Pulmonary Disease (COPD) (NCT03256695) | Teva Branded Pharmaceutical Products R&D, Inc. | 2017-09-28 |